Cannabidiol Market Size to Hit USD 27.57 Billion by 2032, says Coherent Market Insights
Burlingame, CA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The Cannabidiol Market is estimated to be valued at USD 9.46 Bn in 2025 and is expected to reach USD 27.57 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032. The cannabidiol market is projected to experience steady growth during the forecast period, driven by rising R&D investments and the expanding legalization of medical cannabis across multiple regions. Increasing health awareness and broader acceptance of cannabidiol’s therapeutic benefits in managing diverse health conditions are further expected to boost global investment and market expansion.
Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/4613
Global Cannabidiol Market Key Takeaways
Hemp remains the most widely used source for cannabidiol production, with the target segment expected to account for 58.6% of the global cannabidiol market share in 2025.
Cannabidiol oil is projected to remain the top-selling product during the forecast period.
Cannabidiol consumption is expected to remain high in medical applications throughout the projection period.
North America is set to account for over two-fifths of the global cannabidiol industry share in 2025, making it the market leader.
Asia Pacific is poised to emerge as the most lucrative pocket for cannabidiol manufacturers over the forecast period.
Increasing Acceptance and Legalization Fueling Market Growth
Coherent Market Insights’ new cannabidiol market analysis outlines prominent factors driving industry growth. One such key growth factor is the increasing acceptance and legalization of cannabidiol (CBD).
Many nations are easing laws around hemp-derived cannabidiol. As of September 2025, nearly 50 countries have fully or partially legalized cannabis for medical and/or recreational use. For instance,
In December 2024, Japan changed its laws to allow the use of cannabis-derived drugs containing CBD.
In August 2024, Ukraine legalized medical cannabis, including CBD products, for patients with prescriptions.
This wave of legalization is increasing consumer access and demand for CBD products. It is creating a more stable market as well as encouraging businesses to enter the industry.
Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4613
Government Restrictions and Limited Scientific Evidence Limiting Market Growth
The global cannabidiol market outlook appears promising, owing to expanding medical applications. However, government restrictions on CBD usage and limited scientific evidence might limit market growth to some extent during the forthcoming period.
Many countries are putting limits on cannabidiol (CBD) to stop misuse. For example, in June 2025, Italy introduced strict rules on CBD products. This may slow down cannabidiol market growth during the assessment period.
In addition, many health claims about CBD are not fully supported by strong clinical evidence. This makes it difficult for regulators to approve it for medical use. Limited scientific backing may also reduce consumer confidence, thereby dampening overall cannabidiol market demand.
Escalating Demand for Natural Wellness Products Opening Growth Avenues
There is a growing consumer preference for natural and plant-based wellness products in the contemporary world. This is expected to drive demand for cannabidiol due to its perceived health benefits.
Cannabidiol is thought to provide various health benefits, including pain relief, reduced stress and depression, better sleep, and support in managing epilepsy. These potential advantages are driving more people, particularly those seeking natural wellness solutions, to choose CBD.
Emerging Cannabidiol Market Trends
Expanding usage of cannabidiol in medical applications is acting as a catalyst for boosting revenue growth. CBD is increasingly recognized for its potential therapeutic properties, including pain relief, anxiety reduction, and management of conditions like epilepsy and insomnia. For instance, the FDA-approved drug Epidiolex is used to treat seizures associated with certain syndromes.
The wellness and self-care movement is helping CBD market to grow rapidly. This is because CBD is being positioned as part of holistic health and lifestyle, not just medical or recreational. People are increasingly consuming CBD-based products for their perceived wellness benefits like relaxation as well as stress relief.
CBD is gaining immense traction across industries like nutraceuticals and skincare due to its potential health benefits as well as antioxidant and anti-inflammatory properties. Growing adoption across these sectors is expected to boost the cannabidiol market value in the coming years.
Ongoing product diversification will play a key role in fostering sales growth. There is a vast array of CBD-infused products, including edibles, pet wellness products, topicals, and CBD drinks. This variety caters to different consumer preferences and consumption methods, expanding the market’s reach.
Rapid growth of e-commerce and online retail is making CBD-based products more accessible to a wider consumer base. Rising sales of these products through online shopping platforms are expected to boost growth of the cannabidiol market during the forecast period.
Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/4613
Analyst’s View
“The global cannabidiol industry is poised to exhibit strong growth, owing to increasing legalization of CBD, rising demand for natural wellness products, and expanding use of cannabidiol in pharmaceutical, nutraceutical, and skincare sectors,” said a senior CMI analyst.
Current Events and Their Impact on the Cannabidiol Market
| Event | Description and Impact |
| U.S. Federal Cannabis Regulatory Evolution |
|
| Consumer Health and Wellness Market Integration |
|
| Advanced Extraction and Bioavailability Technologies |
|
Competitor Insights
Key companies in cannabidiol market report:
- Cannoid LLC
- ENDOCA
- Medical Marijuana Inc.
- Elixinol
- NuLeaf Naturals LLC
- Folium Biosciences
- Medterra CBD
- Isodiol International Inc.
- Aurora Cannabis Inc.
- CV Sciences
- Pharmahemp d.o.o.
- Canopy Growth Corporation
- Organigram Holding Inc.
- Aphria, Inc.
- GW Pharmaceuticals Plc
Key Developments
In September 2024, Bedrocan announced the launch of a new high-CBD cannabis product called Bedrolina. It contains about 14% CBD. Most of the production will take place at the company’s new EU-GMP-certified facility in Køge, Denmark.
In June 2024, DSM-firmenich announced the launch of CBtru, an advanced formulated CBD drug product intermediate designed for oral solid delivery formats. This new product will allow companies to create more convenient and patient-friendly dosage forms like tablets and chewables.
Market Segmentation
Source Type Insights (Revenue, USD Bn, 2020 - 2032)
- Hemp
- Marijuana
Product Insights (Revenue, USD Bn, 2020 - 2032)
- Oil
- Tinctures
- Suppository
- Transdermal patches
- Vape Oil
- Isolates
- Creams and Roll-on
- Capsules
- Tablet
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Online Stores
- Retail Stores
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Related Reports:
Medical Marijuana Market Analysis & Forecast for 2025-2032
Legal Marijuana Market Size, Share, Trends & Opportunities for 2025-2032
Cannabidiol Consumer Health Market Outlook for 2025-2032
Our Trusted Partners:
Worldwide Market Reports, Coherent MI, Stratagem Market Insights
Get Recent News:
https://www.coherentmarketinsights.com/news
About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-8-7924-7805 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com For Latest Update Follow Us: LinkedIn | Facebook | Twitter
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
